Suppr超能文献

机器人手术会是可切除食管癌的未来治疗方式吗?:肿瘤学及临床结局的系统文献综述

Is Robotic Surgery the Future for Resectable Esophageal Cancer?: A Systematic Literature Review of Oncological and Clinical Outcomes.

作者信息

Patel Nikhil Manish, Patel Pranav Harshad, Yeung Kai Tai Derek, Monk David, Mohammadi Borzoueh, Mughal Muntzer, Bhogal Ricky Harminder, Allum William, Abbassi-Ghadi Nima, Kumar Sacheen

机构信息

Department of Upper GI Surgery, The Royal Marsden NHS Foundation Trust, London, UK.

The Upper Gastrointestinal Surgical Oncology Research Group, The Institute of Cancer Research, London, UK.

出版信息

Ann Surg Oncol. 2024 Jul;31(7):4281-4297. doi: 10.1245/s10434-024-15148-5. Epub 2024 Mar 13.

Abstract

BACKGROUND

Radical esophagectomy for resectable esophageal cancer is a major surgical intervention, associated with considerable postoperative morbidity. The introduction of robotic surgical platforms in esophagectomy may enhance advantages of minimally invasive surgery enabled by laparoscopy and thoracoscopy, including reduced postoperative pain and pulmonary complications. This systematic review aims to assess the clinical and oncological benefits of robot-assisted esophagectomy.

METHODS

A systematic literature search of the MEDLINE (PubMed), Embase and Cochrane databases was performed for studies published up to 1 August 2023. This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocols and was registered in the PROSPERO database (CRD42022370983). Clinical and oncological outcomes data were extracted following full-text review of eligible studies.

RESULTS

A total of 113 studies (n = 14,701 patients, n = 2455 female) were included. The majority of the studies were retrospective in nature (n = 89, 79%), and cohort studies were the most common type of study design (n = 88, 79%). The median number of patients per study was 54. Sixty-three studies reported using a robotic surgical platform for both the abdominal and thoracic phases of the procedure. The weighted mean incidence of postoperative pneumonia was 11%, anastomotic leak 10%, total length of hospitalisation 15.2 days, and a resection margin clear of the tumour was achieved in 95% of cases.

CONCLUSIONS

There are numerous reported advantages of robot-assisted surgery for resectable esophageal cancer. A correlation between procedural volume and improvements in outcomes with robotic esophagectomy has also been identified. Multicentre comparative clinical studies are essential to identify the true objective benefit on outcomes compared with conventional surgical approaches before robotic surgery is accepted as standard of practice.

摘要

背景

对于可切除的食管癌,根治性食管切除术是一项重大的外科手术干预,术后并发症发生率较高。在食管切除术中引入机器人手术平台可能会增强腹腔镜和胸腔镜实现的微创手术优势,包括减轻术后疼痛和减少肺部并发症。本系统评价旨在评估机器人辅助食管切除术的临床和肿瘤学益处。

方法

对MEDLINE(PubMed)、Embase和Cochrane数据库进行系统文献检索,以查找截至2023年8月1日发表的研究。本评价按照系统评价和Meta分析的首选报告项目(PRISMA)方案进行,并在PROSPERO数据库(CRD42022370983)中注册。在对符合条件的研究进行全文审查后,提取临床和肿瘤学结局数据。

结果

共纳入113项研究(n = 14701例患者,n = 2455例女性)。大多数研究为回顾性研究(n = 89,79%),队列研究是最常见的研究设计类型(n = 88,79%)。每项研究的患者中位数为54例。63项研究报告在手术的腹部和胸部阶段均使用机器人手术平台。术后肺炎的加权平均发生率为11%,吻合口漏为10%,住院总时长为15.2天,95%的病例实现了切缘无肿瘤。

结论

机器人辅助手术治疗可切除食管癌有诸多已报道的优势。还发现了手术量与机器人食管切除术结局改善之间的相关性。在机器人手术被接受为标准术式之前,多中心比较临床研究对于确定与传统手术方法相比在结局方面的真正客观益处至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f891/11164768/b7832178bee5/10434_2024_15148_Fig1a_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验